Thomas Edward Hamilton, Director at Larimar Therapeutics, Inc. (LRMR), bought 100,000 shares at $5.00 ($500K) on 2026-02-27, disclosed to the SEC on 2026-03-02.
Open-market purchase of $500k LRMR by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| LRMR | BUY | 2022-09-20 | $1000K | — | Filing → |
| LRMR | BUY | 2021-07-02 | $992K | — | Filing → |
| NLY | SELL | 2021-05-04 | $734K | — | Filing → |